NLRP3 and irritable bowel syndrome: While A. muciniphila treatment in IBD model mice exhibits the potential to alleviate inflammation through the NLRP3 inflammasome pathway, the activation or inhibition of the NLRP3 inflammasome by A. muciniphila or its component is currently a matter of contention.